MetaCap

Addex Therapeutics (ADXN) vs Enveric Biosciences (ENVB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Addex Therapeutics is the larger company by market cap ($6.1 million vs $6.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ADXN+10.86%ENVB-9.70%
+73%+27%-20%
Oct 7, 20261 yearNov 20, 2026
ADXN+7.81%ENVB-6.90%
+28%+6%-16%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ADXN versus ENVB key metrics
MetricADXNENVB
Share price$3.47$1.35
Market cap$6.08M$6.04M
1-day change+2.06%-4.26%
EPS (TTM)$-7.56$-13.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)—$-8.77M
52-week high$10.43$13.25
52-week low$2.56$1.17
Distance from 52-week high-66.73%-89.81%
Average volume383.35K56.55K
Shares outstanding1.75M4.48M
Employees35
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Addex Therapeutics

ADXN stock →

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.

Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees

About Enveric Biosciences

ENVB stock →

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

ADXN vs ENVB FAQ

Which is bigger, Addex Therapeutics or Enveric Biosciences?

Addex Therapeutics (ADXN) is larger, with a market capitalization of $6.08M compared with $6.04M for Enveric Biosciences (ENVB).

Are Addex Therapeutics and Enveric Biosciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons